Technical Analysis for IDYA - IDEAYA Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Crossed Above 20 DMA | Bullish | 1.30% | |
| NR7 | Range Contraction | 1.30% | |
| Multiple of Ten Bullish | Other | 1.30% | |
| 20 DMA Resistance | Bearish | 1.30% | |
| MACD Bullish Signal Line Cross | Bullish | 1.30% | |
| Multiple of Ten Bullish | Other | 1.30% | |
| Multiple of Ten Bearish | Other | 3.10% | |
| Gapped Down | Weakness | 6.63% |
| Alert | Time |
|---|---|
| Up 1 ATR | about 4 hours ago |
| 60 Minute Opening Range Breakout | about 4 hours ago |
| Up 3% | about 4 hours ago |
| 20 DMA Support | about 7 hours ago |
| Fell Below 20 DMA | about 7 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/07/2024
IDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing. IDEAYA is applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Drug Discovery Medical Genetics Biomarkers Medical Test Precision Medicine Molecular Diagnostics Targeted Therapy Systems Biology Synthetic Lethality
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Drug Discovery Medical Genetics Biomarkers Medical Test Precision Medicine Molecular Diagnostics Targeted Therapy Systems Biology Synthetic Lethality
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.735 |
| 52 Week Low | 18.5 |
| Average Volume | 702,965 |
| 200-Day Moving Average | 34.06 |
| 50-Day Moving Average | 42.89 |
| 20-Day Moving Average | 40.57 |
| 10-Day Moving Average | 39.23 |
| Average True Range | 1.75 |
| RSI (14) | 50.74 |
| ADX | 20.71 |
| +DI | 21.75 |
| -DI | 21.67 |
| Chandelier Exit (Long, 3 ATRs) | 38.60 |
| Chandelier Exit (Short, 3 ATRs) | 41.82 |
| Upper Bollinger Bands | 44.09 |
| Lower Bollinger Band | 37.04 |
| Percent B (%b) | 0.59 |
| BandWidth | 17.38 |
| MACD Line | -0.76 |
| MACD Signal Line | -1.02 |
| MACD Histogram | 0.2594 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 44.16 | ||||
| Resistance 3 (R3) | 44.25 | 43.35 | 43.66 | ||
| Resistance 2 (R2) | 43.35 | 42.59 | 43.30 | 43.50 | |
| Resistance 1 (R1) | 42.26 | 42.12 | 42.81 | 42.17 | 43.33 |
| Pivot Point | 41.36 | 41.36 | 41.63 | 41.32 | 41.36 |
| Support 1 (S1) | 40.28 | 40.60 | 40.82 | 40.19 | 39.03 |
| Support 2 (S2) | 39.38 | 40.13 | 39.33 | 38.86 | |
| Support 3 (S3) | 38.29 | 39.38 | 38.70 | ||
| Support 4 (S4) | 38.20 |
